| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 06/15/2006 | CA2590078A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
| 06/15/2006 | CA2588979A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 06/15/2006 | CA2588148A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof |
| 06/15/2006 | CA2587429A1 5-aminopyrazole derivatives as pesticidal compounds |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1667983A2 Pyrazole modulators of metabotropic glutamate receptors |
| 06/14/2006 | EP1667959A1 Biphenyloxy-acids |
| 06/14/2006 | EP1507766A4 Synthesis of diaryl pyrazoles |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | DE102004059302A1 3-Cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazole und ihre Verwendung als Herbizide 3-cyclopropyl-4- (3-amino-2-methylbenzoyl) pyrazoles and their use as herbicides |
| 06/14/2006 | CN1788240A Organic photoconductive material and electrophotographic photoreceptor and image forming device using same |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060841 Process for preparing 1-methylindazole-3-carboxylic acid |
| 06/13/2006 | US7060822 2-pyrazolin-5-ones |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | WO2006060762A2 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/08/2006 | WO2006060564A2 Pyrazole azomethines and colorants containing these compounds |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122250 does not require protection and deprotection of side chain functional groups; inter alia novel processes (incorporating Heck reactions) |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | DE102004058059A1 Pyrazol-azomethine und diese Verbindungen enthaltende oxidative Färbemittel Pyrazole azomethine containing these compounds and oxidative dyes |
| 06/08/2006 | CA2589266A1 Pyrazole azomethines and colorants containing these compounds |
| 06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
| 06/07/2006 | EP1666469A1 Plasminogen activator inhibitor-1 inhibitor |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1663997A1 1h-azolyl-methyl-amides, method for the production thereof and use thereof as nitrification inhibitors |
| 06/07/2006 | EP1663987A1 Ophthalmic compositions for treating ocular hypertension |
| 06/07/2006 | EP1663986A1 Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives |
| 06/07/2006 | EP1663985A1 Pesticides |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663914A2 Method for forming a carbon-carbon or carbon-heteroatom bond |
| 06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
| 06/07/2006 | EP1663232A1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 06/07/2006 | EP1663105A2 Cycloalkyl heterocycles for treating hepatitis c virus |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1056725B1 Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7057049 Mitogen-activated protein kinase inhibitors |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
| 06/06/2006 | US7056920 useful for treating disorders or conditions that are associated with CRF or CRF1 receptors, such as anxiety disorders, depression, and stress related disorders |
| 06/06/2006 | US7056892 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 06/06/2006 | US7056354 produces powerful, particularly bright and chromatic color, particularly red shades that are free of or contain very little blue or yellow; resistance to light, bad weather, washing, permanent-waving, perspiration and friction |
| 06/01/2006 | WO2006057448A1 Arylalkanoic acid derivative |
| 06/01/2006 | WO2006056845A1 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
| 06/01/2006 | WO2006035310A3 Process for preparing bicyclic pyrazolyl compounds |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | US20060116414 1-Methyl-3-di- or trifluoromethyl-4-pyrazolyl-o-phenylfluorocarboxanilides: N-(3',4'-dichloro-3-fluoro-1,1'-biphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide; plant fungicides |
| 06/01/2006 | US20060116384 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | CA2588812A1 Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660459A2 Arylsulfonamidobenzylic compounds |
| 05/31/2006 | EP1660455A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1527052B1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/31/2006 | EP1461345B1 Copper deposition using copper formate complexes |
| 05/31/2006 | EP1413305B1 Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence |
| 05/31/2006 | EP1315500A4 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 05/31/2006 | EP1072598B1 Pyrazolinone derivatives |
| 05/31/2006 | CN1780829A Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/30/2006 | US7053112 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 05/30/2006 | US7053107 Antiproliferative agents, angiogenesis inhibitors for treating cancer, eye disorders, diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis; N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7052538 Trisazo dyes for ink jet printing |
| 05/26/2006 | WO2006055184A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
| 05/26/2006 | WO2006053555A2 Pyrazol-3-one and/or pyridazin-3-one derivatives used as inhibitors of lysyl oxidase |
| 05/26/2006 | WO2005118551A3 Thrombopoietin activity modulating compounds and methods |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2587678A1 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
| 05/25/2006 | US20060111574 Via lithium bis(trimethylsilyl)amide, lithium dicyclohexylamide, or potassium bis(trimethylsilyl)amide base and alkylating agent; atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, multiple sclerosis and rheumatoid arthritis |
| 05/25/2006 | US20060111422 hypocholesterolemic and hypolipidemic agents; hypertriglyceridemia, atherosclerosis, Alzheimer's Disease, benign prostatic hypertrophy (BPH), diabetes and osteoporosis; (3R, 5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxy-heptanoic acid |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111418 Blood-brain barrier disruption inhibitor |
| 05/25/2006 | US20060111412 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/24/2006 | EP1659115A1 Synthesis of substituted 2H-indazole derivatives as anti-angiogenic agents |
| 05/24/2006 | EP1658274A2 Inhibitors of cathepsin s |
| 05/24/2006 | EP1658272A1 Novel gamma-secretase inhibitors |